12/4
07:00 am
mplt
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
High
Report
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
11/26
06:43 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
11/26
06:43 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Zacks Research to a "hold" rating.
11/22
07:57 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
11/22
02:11 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was downgraded by analysts at
Wall S
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was downgraded by analysts at
Wall S
11/21
08:05 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $30.00 price target on the stock.
11/21
07:08 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was given a new $28.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was given a new $28.00 price target on by analysts at Stifel Nicolaus.
11/21
06:04 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
11/21
06:04 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
11/5
01:17 pm
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
Low
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
10/29
09:06 am
mplt
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Low
Report
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
10/26
05:30 pm
mplt
MapLight Therapeutics Announces Pricing of Initial Public Offering
Medium
Report
MapLight Therapeutics Announces Pricing of Initial Public Offering